DataLookout Blog

Weekly intelligence on clinical trial activity, competitive moves, and pipeline trends. All data sourced from ClinicalTrials.gov.

All posts

The One-Word Test for Abandoned Clinical Trials
We Can Now Show You Which Trials Are at Risk
Crohn's and Colitis: The $18 Billion Bet on One New Drug Target
The MASH Pipeline in 2026: Two Approvals, $8 Billion in M&A, and 16 Phase 3 Trials
1,283 Trials, Three Arms Races: The Lung Cancer Pipeline Right Now
The Alzheimer's Pipeline After Semaglutide: Who's Still in the Race
The Obesity Pipeline Has 951 Trials and One Clear Leader
Stop Manually Checking ClinicalTrials.gov